Racial and ethnic disparities persist in the treatment of metastatic cancer among Medicare fee-for-service beneficiaries, with significant differences in receipt of systemic therapy for lung and other common cancers, according to research published August 27 in the Journal of Clinical Oncology . The analysis was led by John K. Lin , M.D., M.S.H.P., of the Department of Health Services Research at The University of Texas MD Anderson Cancer Center.

Disparities in cancer outcomes have been well documented , with Black patients facing worse survival and lower utilization of newer therapies compared with White patients. Inequities occur at multiple steps in what is known as the cancer treatment cascade, beginning with diagnosis and oncology referral and extending through systemic t

See Full Page